Salud Mental

Correlation between intake of omega-3 fatty acids and depressive and anxiety symptoms during pregnancy

##plugins.themes.bootstrap3.article.main##

Miriam Álvarez-Ramírez
Ma. Asunción Lara
José Miguel Cervantes-Alfaro
Virginia Angélica Robinson-Fuentes
Jesús Alveano-Hernández

Abstract

Introduction. Anxiety and depression during pregnancy are disabling disorders associated to complications during the pregnancy, delivery, and postpartum period, with a significant prevalence, between 9 and 20%, hence its importance. Nutritional factors, such as omega-3 fatty acids (ω-3FA) deficiency, have been related with both disorders during pregnancy, especially docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA).

Objective. To evaluate the association between dietary intake of EPA and DHA, and anxiety symptoms (AS) and depressive symptoms (DS) in Mexican pregnant women.

Method. The sample consisted of 151 women in the second trimester of pregnancy. Instruments included a Food Frequency Questionnaire, the Trait Anxiety Inventory, and the Edinburgh Postnatal Depression Scale.

Results. A daily intake of DHA and EPA of 70 mg/d and 30 mg/d, respectively, was found. The prevalence of AS was 44.4%, and 17.9% for DS. We also found the correlation negatively moderate between dietary intake of DHA and EPA and AS (p = .003, p = .017) and DS (p = .001, p = .020) in the group of women who had a severely insufficient intake of ω-3FA.

Discussion and conclusion. The statistical significance shows a negative correlation between variables and the dietary intake of ω-3FA explains in a very small percentage the variability of AS and DS, according to their coefficient of determination. These results suggest the need for an investigation of this relationship through interventional studies.

Keywords:
Fatty acids, omega-3, prenatal anxiety, prenatal depression

References

Almanza-Muñoz J, Salas-Cruz C, Olivares-Morales A. (2011). Prevalencia de depresión postparto y factores asociados en pacientes puérperas de la Clínica de especialidades de la Mujer. Rev Sanid Milit Mex, 65(3), 78-86.

Alvarado-Esquivel C, Sifuentes-Álvarez A, Salas-Martínez C, Martínez-García S. (2006). Validation of the Edinburgh Postpartum Depression Scale in a population of puerperal women in Mexico. Clin Pract Epidemiol Ment Health, 2(33), 1-5, doi: 10.1186/1745-0179-2-33.

Bennett H, Einarson A, Taddio A, Koren G, Einarson T. (2004). Depression during pregnancy. Overview of Clinical Factors. Clin Drug Invest, 24(3), 157-179.

Berenzon S, Lara MA, Robles R, Medina-Mora ME. (2013). Depresión: estado del conocimiento y la necesidad de políticas públicas y planes de acción en México. Salud Pública Mex, 55(1), 74-80.

Ceballos-Martínez I, Sandoval-Jurado L, Jaimes-Mundo E, Medina-Peralta G, Madera-Gamboa J, Fernández-Arias YF. (2010). Depresión durante el embarazo Epidemiología en mujeres mexicanas. Rev Med Inst Mex Seguro Soc, 48(1), 71-74.

Ding Z, Wu Y, Xu S, Zhu R, Jia X, Zhan S, Huang K, Zhu P, Hao J, Tao F. (2014). Maternal anxiety during pregnancy and adverse birth outcomes: A systematic review and meta-analysis of prospective cohort studies. J Affect Disord, 159, 103-110. doi: 10.1016/j.jad.2014.02.027.

Fadzil A, Balakrishnan K, Razali R, Sidi H, Malapan T, Japaraj R, Midin M, Jaafar N, Das S, Manaf A. (2012). Risk factors for depression and anxiety among pregnant women in Hospital Tuanku Bainum, Ipoh, Malaysia. Asia Pac Psychiatry, 5, 7-13. doi: 10.1111/appy.12036.

Genovez MG, Le HN. (2011). Identification of Salvadoran Pregnant Women at risk for Postpartum Depression. In: Poster presentation, 25th Annual Conference Postpartum Support International, Sept 14-18; Seattle, WA.

Grosso G, Galvano F, Marventano S, Malaguarnera M, Bucolo C, Drago F, Caraci F. (2014). Omega-3 fatty acids and depression: Scientific Evidence and Biological Mechanisms. Hindawi Publishing Corporation. Oxid Med Cell Longev, 1-16. http://dx.doi.org/10.1155/2014/313570

Hanley G, Oberlander T. (2014). The effect of perinatal exposures on the infant: antidepressants and depression. Best Pract Res Clin Obstet Gynaecol, 28, 37-48. doi: 10.1016/j.bpobgyn.2013.09.001.

Hernández-Ávila M, Romieu I, Parra S, Hernández-Ávila JE, Madrigal H, Willett W. (1998). Validity and reproducibility a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica Mex, 40, 133-140.

Hibbeln JR. (2002). Seafood consumption, the DHA content of mothers’ milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J Affect Disord, 69, 15–29.

Hoffmire C, Block R, Thevenet-Morrison K, van Wijngaarden E. (2012). Associations between omega-3 poly-unsaturated fatty acids from fish consumption and severity of depressive symptoms. An analysis of the 2005-2008 National Health and Nutrition Examination Survey. Prostaglandins Leukot Essent Fatty Acids, 86:155-160. doi: 10.1016/j.plefa.2012.03.003.

Lara MA, Navarrete L, Nieto L, Barba JP, Navarro JL, Lara-Tapia H. (2015). Prevalence and incidence of perinatal depression and depressive symptoms among Mexican women. J Affect Dis, 175, 18-24. http://dx.doi.org/10.1016/j.jad.2014.12.035.

Lara MA. (2014). Perinatal Depression in Mexican Women: Prevalence, Risk Factors, and Prevention of Postpartum Depression. In:Wisner K, Lara-Cinisomo S, ed. Perinatal Depression Among Spanish-Speaking and Latin American Women. A Global Perspective on Detection and Treatment. New York: Springer, 1-13, doi: 10.1007/978-1-4614-8045-7.

Li Y, Dai Q, Ekperi LI, Dehal A y Zhang J. (2011). Fish consumption and severely depressed mood, findings from the first national nutrition follow-up study. Psychiatry Res, 190, 103-109. doi: 10.1016/j.psychres.2011.05.012.

Liu, J, Green P, Mann J, Rapoport S, Sublette E. (2015). Pathways of polyunsaturated fatty acid utilization: Implications for brain function in neuropsychiatric health and disease. Brain Res, 1597:220-246. doi: 10.1016/j.brainres.2014.11.059.

Markhus M, Skotheim S, Eide I, Livar F, Cecilie H, Morten K, Kjellevold M. (2013). Low Omega-3 Index in Pregnancy Is a Possible Biological Risk Factor for Postpartum Depression. PLOS ONE, 8(7), 1-12.

http://dx.doi.org/10.1371/journal.pone.0067617.

Meades R, Ayers S. (2011). Anxiety measures validated in perinatal populations: A systematic review. J Affect Disord, 133, 1-15, doi: 10.1016/j.jad.2010.10.009

Mizunoya W, Ohnuki K, Baba K, Miyahara H, Shimizu N, Tabata K, Kno T, Sato Y, Tatsumi R, Ikeuchi Y. (2013). Effect of dietary fat type on anxiety-like and depression-like behavior in mice. Springer Plus, 2(165), 1-9. doi: 10.1186/2193-1801-2-165.

Morse N. (2012). Benefits of Docosahexaenoic Acid, Folic Acid, Vitamin D and Iodine on Foetal and Infant Brain Development and Function Following Maternal Supplementation during Pregnancy and Lactation. Nutrients, 4, 799-840. doi: 10.3390/nu4070799.

Navarrete LE, Lara MA, Navarro C, Gómez ME, Morales F. (2012). Factores psicosociales que predicen síntomas de ansiedad postnatal y su relación con los síntomas depresivos en el postparto. Rev Invest Clin, 64(6), 625-633.

Oppo A, Mauri M, Ramacciotti D, Camilleri V, Banti S, Borri C, Rambelli C, Montagnani MS, Cortopassi S, Bettini A, Ricciardulli S, Montaresi S, Rucci P, Beck CT, Cassano GB. (2009). Risk factors for postpartum depression: the role of the Postpartum Depression Predictors Inventory-Revised (PDPI-R). Results from the Perinatal Depression-Research & Screening Unit (PNDReScU) study. Arch Women Ment Health, 12(4), 239-49. doi: 10.1007/s00737-009-0071-8.

Parra MS, Schnaas L, Meydan M, Perroni E, Martínez S, Romieu I. (2002). Erythrocyte cell membrane phospholipids levels compared against reported dietary intakes of polyunsaturated FA in pregnant Mexican women. Public Health Nutr, 5(6A), 931-937, doi: 10.1079/PHN2002381.

Rahman A, Fisher J, Bower P, Luchters S, Tran T, Yasamy MT, Saxena S, Waheed W. (2013). Interventions for common perinatal mental disorders in women in low- and middle- income countries: a systematic review and meta-analysis. Bull World Health Organ, 91, 593-601. doi: 10.2471/BLT.12.109819.

Ramírez-Silva I, Villalpando S, Moreno-Saracho J, Bernal-Medina D. (2011). Fatty acids intake in the Mexican population. Results of the National Nutrition Survey 2006. Nutr & Metab, 8(33), 1-10, doi: 10.1186/1743-7075-8-33.

Records K, Rice M, Beck CT. (2007). Psychometric assessment of the Postpartum Depression Predictors Inventory-Revised. J Nurs Meas, 15(3), 189-202.

Rosario-Juárez I, Santos-García R, Lara-Cantú MA, Almanza-Muñoz JJ. (2009). Consistencia interna y análisis factorial de la Escala de Depresión Postparto de Edimburgo en mujeres mexicanas embarazadas y puérperas. Reporte preliminar. Neurol Neurocir Psiquiat, 42(1-4), 1-6.

Rubertsson C, Hellström J, Cross M, Sydsjö G. (2014). Anxiety in early pregnancy: prevalence and contributing factors. Arch Women Ment Health, 17, 221-228. doi: 10.1007/s00737-013-0409-0

Simopoulos AP. (2011). Evolutionary Aspects of Diet: The Omega-6/Omega-3 Ratio and the Brain. Mol Neurobiol; 44, 203-215. doi: 10.1007/s12035-010-8162-0.

Spielberger C, Díaz-Guerrero R. (1975). IDARE Inventario de Ansiedad: Rasgo-Estado. Manual e Instructivo. México: El Manual Moderno, 1-28.

Su KP, Matsuoka Y, Pae CU. (2015). Omega-3 Polyunsaturated Fatty Acids in Prevention of Mood and Anxiety Disorders. J Clin Psychopharmacol, 13(2), 129-137. doi: 10.9758/cpn.2015.13.2.129.

Van Eijsden M, Hornstra G, van der Wal M, Vrijkotte T, Bonsel G. (2008). Maternal n-3, n-6, and trans fatty acid profile early in pregnancy and term birth weight: a prospective cohort study. Am J Clin Nutr, 87, 887-95.

Vaz J, Kac G, Emmett P, Davis JM, Golding J, Hibbeln J. (2013). Dietary Patterns, n-3 Fatty Acids Intake from Seafood and High Levels of Anxiety Symptoms during Pregnancy Findings from the Avon Longitudinal Study of Parents and Children. PLOS ONE, 8(7), 1-9, doi: 10.1371/journal.pone.0067671.

Wisner KL, Lara-Cinisomo S, Pinheiro E, Luther J. (2014). Characteristics of Hispanic Women Screened for Postpartum Depression. In: Wisner K, Lara-Cinisomo S, ed. Perinatal Depression Among Spanish-Speaking and Latin American Women. A Global Perspective on Detection and Treatment. New York: Springer, 1-13, doi: 10.1007/978-1-4614-8045-7_1

World Medical Association. (2013). Declaración de Helsinki. Principios éticos para las investigaciones con seres humanos. 64ª Asamblea General, Fortaleza, Brasil, octubre de 2013 [en línea]. [Fecha de consulta: 01 de septiembre de 2014].